Treatment of human melanoma with a hapten-modified autologous vaccine.
Berd
D
D
Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania 19107.
Maguire
H C
HC
Mastrangelo
M J
MJ
D003520:Cyclophosphamide / Q000627:therapeutic use; D003602:Cytotoxicity, Immunologic; D004136:Dinitrobenzenes / Q000276:immunology; D006241:Haptens; D006801:Humans; D016233:Immunotherapy, Active; D008545:Melanoma / Q000628:therapy*; D009362:Neoplasm Metastasis; D016019:Survival Analysis; D013601:T-Lymphocytes / Q000276:immunology
D004136:Dinitrobenzenes; D006241:Haptens; D003520:Cyclophosphamide